Effect of curcumin (tumeric) in Alzheimer's disease
Not Applicable
- Conditions
- Alzheimer's disease.Alzheimer disease with late onset
- Registration Number
- IRCT201507271165N11
- Lead Sponsor
- Vice Chancellor for Baghiyatallah University of Medical Sciences, Chemical Injeries Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Inclusion Criteria : Sign informed consent ; mild Alzheimer; with out any of psychic disorder
Exclusion Criteria : Discontinue of treatment more than 2 weeks ; disese becomes out of control ; allergic reaction to herbal compounds ,abnormal results in lab tests
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvment of mental state. Timepoint: before and after of intervention (12 weeks). Method of measurement: MMSE questionaire.;Improvment of quality of life. Timepoint: before and after of intervention (12 weeks). Method of measurement: quality of life questionnaire.
- Secondary Outcome Measures
Name Time Method Interleukin18 (IL18). Timepoint: befor and after of intervention(12 weeks). Method of measurement: level of serum.;Superoxide dismutase (SOD). Timepoint: before and after of intervention(12 weeks). Method of measurement: level of serum.;Glutathione peroxidase (GPO). Timepoint: before and after of intervention(12 weeks). Method of measurement: level of serum.;Malondialdehyde(MDA). Timepoint: befor and after of intervention(12 weeks). Method of measurement: level of serum.